High-dose nimotuzumab improves the survival rate of esophageal cancer patients who underwent radiotherapy

High-dose nimotuzumab improves the survival rate of esophageal cancer patients who underwent radiotherapy

Chunyu Wang,1,2 Xiaolong Fu,3 Xuwei Cai,3 Xianghua Wu,4 Xichun Hu,4 Min Fan,1,2 Jiaqing Xiang,5 Yawei Zhang,5 Haiquan Chen,5 Guoliang Jiang,1,2 Kuaile Zhao1,2 1Department of Radiation Oncology, Fudan University Shanghai Cancer Center, 2Department of Oncology, Shanghai Medical College, Fudan Univers...

Full description

Bibliographic Details
Main Authors: Wang CY, Fu XL, Cai XW, Wu XH, Hu XC, Fan M, Xiang JQ, Zhang YW, Chen HQ, Jiang GL, Zhao KL
Format: Article
Language:English
Published: Dove Medical Press 2015-12-01
Series:OncoTargets and Therapy
Subjects:
Esophageal squamous cell carcinoma
epidermal growth factor receptor
monoclonal antibody
nimotuzumab
Online Access:https://www.dovepress.com/high-dose-nimotuzumab-improves-the-survival-rate-of-esophageal-cancer--peer-reviewed-article-OTT

Internet

https://www.dovepress.com/high-dose-nimotuzumab-improves-the-survival-rate-of-esophageal-cancer--peer-reviewed-article-OTT

Similar Items